MedTrace Logo

Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea

NCT02736539 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2017-07-21

No results posted yet for this study

Summary

This study is designed as a randomized double-blinded treatment trial among travelers' to geographical areas with moderate-severe rates of traveler's diarrhea. Travelers will be randomized to receive CBS 2004 or masked placebo to be taken daily while traveling. The test article or placebo will be taken starting 7 days prior to travel.

Conditions

  • Traveler's Diarrhea

Interventions

DRUG

CBS 2004 (galacto-oligosaccharides)

CBS 2004 active treatment

DRUG

Placebo

Placebo treatment

Sponsors & Collaborators

  • Clasado Biosciences Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-15
Primary Completion
2018-12-31
Completion
2019-02-28
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02736539 on ClinicalTrials.gov